Suchergebnisse - "de Andrade, Danieli"

PubPharm (6)

1

Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients : Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry")

enthalten in: Seminars in arthritis and rheumatism | 2024

von Yelnik, C. | Erton, Z. | Drumez, E. | +34

2

Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome : A four-year prospective study

enthalten in: Lupus | 2020

von Nascimento, I. | Radin, M. | Gândara, A. | +2

3

Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS)

enthalten in: Advances in rheumatology (London, England) | 2020

von Balbi, G. | Pacheco, M. | Monticielo, O. | +6

4

Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS)

enthalten in: Advances in rheumatology | 2020

von Balbi, G. | Pacheco, M. | Monticielo, O. | +6

5

Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS)

enthalten in: Advances in rheumatology | 2020

von Balbi, G. | Pacheco, M. | Monticielo, O. | +6

6

Enhanced type I interferon gene signature in primary antiphospholipid syndrome : Association with earlier disease onset and preeclampsia

enthalten in: Autoimmunity reviews | 2019

von Ugolini-Lopes, M. | Torrezan, G. | Gândara, A. | +6

1
[1]